Home Health Novo Nordisk Ozempic trial delays development of power kidney illness – ET HealthWorld | Pharma

Novo Nordisk Ozempic trial delays development of power kidney illness – ET HealthWorld | Pharma

0
Novo Nordisk Ozempic trial delays development of power kidney illness – ET HealthWorld | Pharma

[ad_1]

"The trial achieved its major endpoint by demonstrating a statistically vital and superior discount in kidney illness development, main hostile cardiovascular occasions (MACE) and demise of 24%," it mentioned in an announcement

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here